These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 526987)

  • 1. [Buformin-influenced calcium absorption (author's transl)].
    Brunová E; Kocián J; Slabochová Z; Vondra K
    Cas Lek Cesk; 1979 Aug; 118(31):975-8. PubMed ID: 526987
    [No Abstract]   [Full Text] [Related]  

  • 2. [A contribution to the study of the effect of bigvanides in the skeletal muscle of diabetics (author's transl)].
    Vondra K; Bass A; Brunová E; Slabochová Z; Teisinger J; Vítek V
    Cas Lek Cesk; 1978 Jul; 117(29-30):892-4. PubMed ID: 688313
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of IRI and some blood lipid indices after buformin administration].
    Quartarone M; Saitta A; Caruso G; Monacciani U; Perdichizzi G; Squadrito G
    Minerva Med; 1979 May; 70(22):1623-8. PubMed ID: 450301
    [No Abstract]   [Full Text] [Related]  

  • 4. [Follow-up study on the effects of buformin on the serum vitamin B-12 level and on the motility of the stomach and small intestine in diabetics].
    Brunová E; Slabochová Z; Hrubá F; Nováková V; Bejblová O; Vondra K
    Vnitr Lek; 1978 Mar; 24(3):277-81. PubMed ID: 644896
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vitamin B 12 absorption disorders in diabetic patients treated with adebit].
    Keszthelyi B; Tóth A; Novotny S; Fónay K; Jávor T; Past T; Bero T
    Orv Hetil; 1976 Apr; 117(16):963-4. PubMed ID: 1272562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antagonistic action of prednisolone and buformin in the carbohydrate metabolism of healthy persons (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Feb; 71(7):275-80. PubMed ID: 815773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Sep; 71(36):1423-8. PubMed ID: 958105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.
    Tutwiler GF; Bridi G
    Diabetes; 1978 Aug; 27(8):868-76. PubMed ID: 680413
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vitamin B12-level in serum of diabetics receiving long-term buformin therapy].
    Müller P; Fischer H; Sorger D
    Z Gesamte Inn Med; 1981 Mar; 36(6):226-8. PubMed ID: 7257460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of Buformin retard in adipose patients with impaired glucose tolerance].
    Schräpler P; Schulz E; Adlung J
    Med Welt; 1975 Oct; 26(42):1919-21. PubMed ID: 1186481
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of ethanol absorption by butyl-biguanide in rat gastrointestinal tract in vivo.
    Debreceni L; Tóth E; Csete B
    Res Exp Med (Berl); 1984; 184(3):205-8. PubMed ID: 6473906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparative studies of the effect of N1-n-butylbiguanide hydrochloride (Buformin) and N1-n-butylbiguanide tosylate (Buformin retard)].
    Singer P; Thoelke H
    Z Gesamte Inn Med; 1973 Aug; 28(16):504-6. PubMed ID: 4767598
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of lactic acidosis with biguanide therapy.
    Botha JL; Vinik AI; Jackson WP
    S Afr Med J; 1977 Aug; 52(8):301-2. PubMed ID: 897932
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of intestinal calcium transport by antidiabetic biguanides.
    Wróbel J; Michalska L; Nagel G
    Gen Pharmacol; 1979; 10(3):269-73. PubMed ID: 467964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of butylbiguanide in retard form on the glucose resorption and lactate-pyruvate concentration in blood].
    Schräpler P; Schulz E; Nijssen J; Adlung J
    Med Welt; 1977 Mar; 28(9):422-6. PubMed ID: 846382
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of a biguanide (buformin) on carnitine palmitoyltransferase activity.
    Sándor A; Kerner J; Alkonyi I
    Acta Biochim Biophys Acad Sci Hung; 1977; 12(3):217-21. PubMed ID: 602670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate effects of buformin on muscle metabolism.
    Strohfeldt P; Kettl H; Obermaier U; Weinges KF
    Horm Metab Res; 1975 Jul; 7(4):355. PubMed ID: 1150135
    [No Abstract]   [Full Text] [Related]  

  • 19. [The biguanides in the treatment of late florid diabetes of recent diagnosis: controlled trial of delayed-action buformin and placebo].
    Angeli G; Baraldi B; Ciaramelli F
    Clin Ter; 1977 Jun; 81(5):453-62. PubMed ID: 328220
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharmacological effects of biguanides on intestinal motility and absorption].
    Pelosio L; Marasco A; Naim U
    Clin Ter; 1979 Sep; 90(5):509-16. PubMed ID: 399211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.